<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">0213264</journal-id>
<journal-id journal-id-type="pubmed-jr-id">1117</journal-id>
<journal-id journal-id-type="nlm-ta">Biol Psychiatry</journal-id>
<journal-id journal-id-type="iso-abbrev">Biol. Psychiatry</journal-id>
<journal-title-group>
<journal-title>Biological psychiatry</journal-title>
</journal-title-group>
<issn pub-type="ppub">0006-3223</issn>
<issn pub-type="epub">1873-2402</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">27086544</article-id>
<article-id pub-id-type="pmc">5001930</article-id>
<article-id pub-id-type="doi">10.1016/j.biopsych.2016.02.022</article-id>
<article-id pub-id-type="manuscript">NIHMS783802</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Receptor Tyrosine Kinase MET Interactome and Neurodevelopmental Disorder Partners at the Developing Synapse</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Xie</surname>
<given-names>Zhihui</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Li</surname>
<given-names>Jing</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Baker</surname>
<given-names>Jonathan</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Eagleson</surname>
<given-names>Kathie L.</given-names>
</name>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Coba</surname>
<given-names>Marcelo P.</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Levitt</surname>
<given-names>Pat</given-names>
</name>
<xref ref-type="aff" rid="A4">4</xref>
<xref ref-type="aff" rid="A5">5</xref>
<xref ref-type="author-notes" rid="FN1">*</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>Department of Pediatrics and The Saban Research Institute, Children’s Hospital Los Angeles, Los Angeles, CA 90027</aff>
<aff id="A2"><label>2</label>Zilkha Neurogenetic Institute, Keck School of Medicine of the University of Southern California, Los Angeles, CA 90089</aff>
<aff id="A3"><label>3</label>University of Notre Dame, South Bend, IN 46556</aff>
<aff id="A4"><label>4</label>Dept. Pediatrics, Children’s Hospital Los Angeles and the Keck School of Medicine of the University of Southern California, Los Angeles, CA 90027</aff>
<aff id="A5"><label>5</label>Program in Developmental Neurogenetics, Institute for the Developing Mind and The Saban Research Institute, Children’s Hospital Los Angeles, Los Angeles, CA 90027</aff>
<author-notes>
<corresp id="FN1"><label>*</label>Corresponding Author: Pat Levitt, PhD, <email>plevitt@med.usc.edu</email></corresp>
<fn fn-type="COI-statement" id="FN3">
<p>
<bold>Disclosures</bold>
</p>
<p>All authors report no biomedical financial interests or potential conflicts of interest.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>3</day>
<month>6</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="epub">
<day>26</day>
<month>2</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="ppub">
<day>15</day>
<month>12</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>15</day>
<month>6</month>
<year>2017</year>
</pub-date>
<volume>80</volume>
<issue>12</issue>
<fpage>933</fpage>
<lpage>942</lpage>
<!--elocation-id from pubmed: 10.1016/j.biopsych.2016.02.022-->
<abstract>
<sec id="S1">
<title>Background</title>
<p id="P1">Atypical synapse development and plasticity are implicated in many neurodevelopmental disorders (NDDs). NDD-associated, high confidence risk genes have been identified, yet little is known about functional relationships at the level of protein-protein interactions, which are the dominant molecular bases responsible for mediating circuit development.</p>
</sec>
<sec id="S2">
<title>Methods</title>
<p id="P2">Proteomics in three independent developing neocortical synaptosomal preparations identified putative interacting proteins of the ligand-activated MET receptor tyrosine kinase, an autism risk gene that mediates synapse development. The candidates were translated into interactome networks and analyzed bioinformatically. Additionally, three independent quantitative proximity ligation assays (PLA) in cultured neurons and four independent immunoprecipitation analyses of synaptosomes validated protein interactions.</p>
</sec>
<sec id="S3">
<title>Results</title>
<p id="P3">Approximately 11% (8/72) of MET-interacting proteins, including SHANK3, SYNGAP1 and GRIN2B, are associated with NDDs. Proteins in the MET interactome were translated into a novel MET interactome network based on human protein-protein interaction databases. High confidence genes from different NDD datasets that encode synaptosomal proteins were analyzed for being enriched in MET interactome proteins. This was found for autism, but not schizophrenia, bipolar disorder, major depressive disorder or attentional deficit hyperactivity disorder. There is correlated gene expression between <italic>MET</italic> and its interactive partners in developing human temporal and visual neocortices, but not with highly expressed genes that are not in the interactome. PLA and biochemical analyses demonstrate that MET-protein partner interactions are dynamically regulated by receptor activation.</p>
</sec>
<sec id="S4">
<title>Conclusions</title>
<p id="P4">The results provide a novel molecular framework for deciphering the functional relations of key regulators of synaptogenesis that contribute to both typical cortical development and to NDDs.</p>
</sec>
</abstract>
<kwd-group>
<kwd>proteomics</kwd>
<kwd>synaptogenesis</kwd>
<kwd>neocortex</kwd>
<kwd>mental illnesses</kwd>
<kwd>autism</kwd>
<kwd>interactome</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>